Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu
ChartWise Medical Systems, Inc.

Canaccord Genuity acts as Exclusive Financial Advisor to ChartWise Medical Systems on its acquisition by Iodine Software

Canaccord Genuity is pleased to announce that on May 26, 2021, ChartWise Medical Systems, Inc. was acquired by Iodine Software, LLC, a portfolio company of Silversmith Capital Partners and Bain Capital Ventures. Canaccord Genuity acted as exclusive financial advisor to ChartWise.

ChartWise provides hospitals and health systems the industry-leading clinical documentation integrity (“CDI”) software platform that leverages AI, natural language processing and case prioritization capabilities to enhance the accuracy, specificity and completeness of clinical documentation. Through improved coding performance, ChartWise enables clients to ensure full reimbursement, prevent denials and transition to value-based and risk-adjusted models of care. The Company’s end-to-end CDI software solution with emerging outpatient capabilities was recently named “Best in KLAS” ahead of notable competitors 3M, Nuance and Optum.

Press Releases
Lead Transaction Banker

More like this

ChartWise Medical Systems, Inc.
June 2021

ChartWise Medical Systems, Inc.

Financial Advisor to ChartWise Medical Systems, Inc. on its sale to Iodine Software, a portfolio company of Silversmith Capital Partners and Bain Capital Ventures
View transaction detail
Susquehanna Growth Equity
May 2021

Susquehanna Growth Equity

Financial Advisor to Susquehanna Growth Equity on its Majority Investment in MediSpend
MediSpend logo
View transaction detail
Trulieve
US$2.1b
May 2021

Trulieve

Financial Advisor to Trulieve on its acquisition of Harvest Health & Recreation Inc.